Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer

NCT: NCT07733960 · RECRUITING

NCT IDNCT07733960
StatusRECRUITING
Start Date2026-05-21
Completion2027-07-30
SponsorMedtronic Cardiac Rhythm and Heart Failure (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to collect and compare the heart's electrical activity data measured by the novel Conduction System Pacing (CSP) Display Research System with data measured via 12 lead electrocardiogram (ECG) from a commercially available, standard of care electro-physiology (EP) monitoring and recording device during the pacemaker implantation. Participants receiving a routine de-novo implantation of a pacemaker for left bundle branch area pacing (LBBAP) will undergo the CSP Display System protocol during the implant procedure.

Frequently Asked Questions

What is Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer?

Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer is a clinical trial registered under NCT07733960. Current status: RECRUITING.

What is the status of NCT07733960?

The current status of NCT07733960 (Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer) is: RECRUITING.

When did Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer start?

Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer started on 2026-05-21.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.